Business
MEDICURE TO PRESENT FINANCIAL RESULTS ON NOVEMBER 25, 2022 CALL at 8:30 AM ET FOR QUARTER ENDED SEPTEMBER 30, 2022
MEDICURE TO PRESENT FINANCIAL RESULTS ON NOVEMBER 25, 2022 CALL at 8:30 AM ET FOR QUARTER...
About this update from Medicure Inc.
[{"type":"text","content":"\n \n \n \n MEDICURE TO PRESENT FINANCIAL RESULTS ON NOVEMBER 25, 2022 CALL at 8:30 AM ET FOR QUARTER ENDED SEPTEMBER 30, 2022\n \n \n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n \n \n \n \n \n \n Canada NewsWire\n \n \n \n \n \n \n WINNIPEG, MB\n \n \n ,\n \n \n Nov. 17, 2022\n \n \n /CNW/ - Medicure Inc. (\"\n \n Medicure\n \n \" or the \"\n \n Company\n \n \") (TSXV: MPH) (OTC: MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in\n \n the United States\n \n market, will present the Q3 Financial Results on a Conference Call on\n \n November 25, 2022\n \n at\n \n 8:30 am Eastern Time\n \n . The Q3 Financials will be filed after closing the day before.\n \n \n \n Conference Call Info:\n \n \n \n Topic:  Medicure's Q3 2022 Results\n \n \n Call date:  Friday, November 25, 2022\n \n \n Time:  7:30 AM Central Time (\n \n 8:30 AM Eastern Time\n \n )\n \n \n \n Canada\n \n toll: 1 (416) 764-8659\n \n \n North American toll-free:  1 (888) 664-6392\n \n \n Passcode:  not required\n \n \n Webcast:    This conference call will be webcast live over the internet and can be accessed from the Medicure investor relations page at the following link:\n \n www.medicure.com/investors\n \n \n \n You may request international country-specific access information by e-mailing the Company in advance. Management will accept and answer questions related to the financial results and operations during the question-and-answer period at the end of the conference call. A recording of the call will be available following the event at the Company's website.\n \n \n \n About Medicure Inc.\n \n \n \n Medicure is a pharmaceutical company focused on the development and commercialization of therapies for the U.S. cardiovascular market. The present focus of the Company is the marketing and distribution of AGGRASTAT\n \n ®\n \n (tirofiban hydrochloride) injection and ZYPITAMAG\n \n ®\n \n (pitavastatin) tablets in\n \n the United States\n \n , where they are sold through the Company'...